Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients (NCT04723706) | Henry Ford Health System | 2021-03-19 |
Track Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART) automatically
Every clearance here is in the API, with alerts when new ones post.